Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 Cases (1990-2001)

Journal of Veterinary Internal Medicine

Volumn 17, Issue 5, 2003, Pages 687-692

  Gieger, Tracy L ^a,c   Théon, Alain P ^a   Werner, Jonathan A ^a   McEntee, Margaret C ^a,d   Rassnick, Kenneth M ^b,d   DeCock, Hilde E V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TUFTS UNIVERSITY   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

^d Department of Obstetrics Gynecology   (United States)

Author keywords

Canine skin tumors; Mastocytosis; Metastasis

Indexed keywords

ARTICLE; BEHAVIOR; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; DOG; DOG DISEASE; HISTOLOGY; MASTOCYTOMA; MEDICAL ASSESSMENT; MEDICAL RECORD; METASTASIS; NONHUMAN; PROGNOSIS; RETROSPECTIVE STUDY;

ANIMALS; CALIFORNIA; DISEASE-FREE SURVIVAL; DOG DISEASES; DOGS; FEMALE; MALE; MAST-CELL SARCOMA; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NOSE; PROGNOSIS; RECORDS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

CANIS FAMILIARIS;

EID: 0141889310     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2003)017<0687:BBAPFF>2.3.CO;2     Document Type: Article

References (27)

1. Dorn ER, Taylor D, Schneider R, et al. Survey of animal neoplasms in Alameda and Contra Costa counties, California. J Natl Cancer Inst 1968;40:307-318.
2. Cohen D, Reif SS, Brodey RS, et al. Epidemiological analysis of the most prevalent sites and types of canine neoplasia observed in a veterinary hospital. Cancer Res 1974;34:2859-2868.
3. Bostock DE. The prognosis following surgical removal of mastocytomas in dogs. J Small Anim Pract 1973;14:27-40.
4. Patnaik AK, Ehler WJ, MacEwen EG. Canine cutaneous mast cell tumor: Morphologic grading and survival time in 83 dogs. Vet Pathol 1984;21:469-474.
5. Turrel JM, Kitchell BE, Miller LM, et al. Prognostic factors for radiation treatment of mast cell tumors in 85 dogs. J Am Vet Med Assoc 1988;193:936-940.
6. Kravis LD, Vail DM, Kisseberth WC, et al. Frequency of argyrophilic nucleolar organizer regions in fine-needle aspirates and biopsy specimens from mast cell tumors in dogs. J Am Vet Med Assoc 1996; 209:1418-1420.
7. Bostock DE, Crocker J, Harris K, et al. Nucleolar organiser regions as indicators of post-surgical prognosis in canine spontaneous mast cell tumors. Br J Cancer 1989;59:915-918.
8. Ayl RD, Couto CG, Hammer AS, et al. Correlation of DNA ploidy to tumor histologic grade, clinical variables, and survival in dogs with mast cell tumors. Vet Pathol 1992;29:386-390.
9. Simoes JPC, Schoning P, Butine M. Prognosis of canine mast cell tumors: A comparison of three methods. Vet Pathol 1994;31:637-647.
10. Miller DM. The occurrence of mast cell tumors in young Shar Peis. J Vet Diagn Invest 1995;7:360-363.
11. Ginn PE, Fox LE, Brower JC, et al. Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors. Vet Pathol 2000;37:33-39.
12. Jaffe MH, Hosgood G, Taylor HW, et al. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors. Vet Pathol 2000;37:40-46.
13. Fan TM, Kitchell BE. Retrospective analysis of oral mast cell tumors in dogs. Proceedings of the 19th Annual Veterinary Cancer Society Conference, Woods Hole, MA, 1999:40.
14. Takahashi T, Kadosawa T, Nagase M, et al. Visceral mast cell tumor in dogs: 10 cases (1982-1997). J Am Vet Med Assoc 2000; 216:222-226.
15. Michels GM, Knapp DW, DeNicola DB, et al. Prognosis following surgical excision of canine cutaneous mast cell tumors with histologically tumor-free versus nontumor-free margins: A retrospective study of 31 cases. J Am Anim Hosp Assoc 2002;38:458-466.
16. Al-Sarraf R, Mauldin GN, Patnaik AK, et al. A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs. J Vet Int Med 1996;10:376-378.
17. Anonymous. Consultation on the biological behavior and therapy of tumors of domestic animals. Geneva: World Health Organization; 1978.
18. Freidman LM, Furberg CD, DeMets DL. Survival analysis. In: Fundamentals of Clinical Trials, 2nd ed. Littleton, MA: PSG Publishing Co Inc; 1985:191-200.
19. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
20. Cox DR. Regression models and life-tables. J Roy Stat Soc 1972;34:187-220.
21. Weisse C, Shofer FS, Sorenmo K. Recurrence rates and sites for Grade II canine cutaneous tumors following complete surgical excision. J Am Anim Hosp Assoc 2002;38:71-73.
22. Hottendorf GH, Neilson SW. Survey of 300 extirpated canine mastocytomas. Zentralbl Vet 1967;14:272-281.
23. Frimberger AE, Moore AS, LaRue SM, et al. Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989-1993). J Am Anim Hosp Assoc 1997;320-324.
24. LaDue T, Price GS, Dodge R, et al. Radiation therapy for incompletely resected canine mast cell tumors. Vet Radiol Ultrasound 1998;39:57-62.
25. Chaffin K, Thrall DE. Results of radiation therapy in 19 dogs with cutaneous mast cell tumors and regional lymph node metastasis. Vet Rad Ultrasound 2002;43:392-395.
26. McManus PM. Frequency and severity of mastocytemia in dogs with and without mast cell tumors: 120 cases (1995-1997). J Am Vet Med Assoc 1999;215:355-357.
27. Gerritsen RJ, Teske E, Kraus JS, et al. Multi-agent chemotherapy for mast cell tumors in the dog. Vet Quart 1998;20:28-31.